Pfizer pullout from Connecticut city puzzles those who lost key eminent domain case

Associated Press

Last update: November 13, 2009 - 2:50 PM

NEW LONDON, Conn. - Now that drug giant Pfizer Inc. has announced plans to pull out of a Connecticut city that was embroiled in an epic eminent domain fight, residents are questioning why the battle was ever waged.

The company said this week that it plans to close its research and development site in New London and move about 1,500 jobs to its Groton campus.

New London officials had sought a city parcel for a private development to complement a new Pfizer research facility. The U.S. Supreme Court ruled against homeowners in a 2005 eminent domain decision.

Pfizer said that it had no stake in the court case and that eminent domain played no part in the development of its building.

Recent Health + Wellness stories

FDA approves first non-hormone therapy for excessive menstrual bleeding - November 13, 2009

FDA approves first non-hormone therapy for excessive menstrual bleeding - Federal health officials have approved a new drug as the first non-hormonal treatment for heavy menstrual bleeding. More

WHO urges organizers of mass gatherings such as World Cup, hajj to keep swine flu in mind - November 13, 2009

WHO urges organizers of mass gatherings such as World Cup, hajj to keep swine flu in mind - Organizers of big sporting and cultural events should take steps to prevent the spread of swine flu, especially if local health systems aren't prepared to handle mass gatherings, the World Health Organization said Friday. More